Compare ZVRA & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | BLMN |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 653.2M | 688.3M |
| IPO Year | 2015 | 2012 |
| Metric | ZVRA | BLMN |
|---|---|---|
| Price | $10.97 | $7.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | ★ $23.00 | $7.88 |
| AVG Volume (30 Days) | 1.8M | ★ 2.7M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.99% |
| EPS Growth | ★ 159.21 | 106.71 |
| EPS | 0.60 | ★ 0.65 |
| Revenue | $106,470,000.00 | ★ $4,213,346,000.00 |
| Revenue This Year | $37.27 | $2.07 |
| Revenue Next Year | $53.42 | $1.81 |
| P/E Ratio | $18.13 | ★ $12.02 |
| Revenue Growth | ★ 350.91 | N/A |
| 52 Week Low | $7.16 | $5.19 |
| 52 Week High | $13.16 | $10.70 |
| Indicator | ZVRA | BLMN |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 52.74 |
| Support Level | $8.26 | $6.97 |
| Resistance Level | $11.07 | $8.15 |
| Average True Range (ATR) | 0.56 | 0.43 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 43.28 | 29.19 |
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.